Telemedicine vs in-person delivery of cognitive behavioral treatment of insomnia: a mixed methods analysis

Telemedicine vs in-person delivery of cognitive behavioral treatment of insomnia: a mixed methods analysis
Recruiting
21 years - 60 years
All
Phase N/A
90 participants needed

Brief description of study

Cognitive behavioral therapy for insomnia (CBT-I) has been the gold standard for the treatment of insomnia. There is a need to increase access to treatment, particularly for patients in more rural locations where providers may be scarce. One solution is to utilize telemedicine which is 'the use of electronic communications to provide and support health care when distance separates the provider from the patient'. So the purpose of the study is to determine if receiving CBT-I by video teleconferencing works just as well as in-person treatment.

Detailed description of study

Your participation will last approximately 5-7 months depending on the group you are randomized in to. The first visit is a screening visit where you will be asked to answer questions about your sleep, thoughts, and feelings as well as a provide a fasting blood draw. If eligible, you will be provided two devices. One is a portable sleep monitoring device that you will wear for one night and a wrist worn device for one week. After study staff receive the devices back you will be randomized in to one of 3 groups: in-person CBT-I, CBT-I via Telemedicine, or a waitlist group where you will wait 8 weeks prior to starting in-person CBT-I. Following treatment, you will be given the wrist worn device to wear for a week and will come in to the office for another fasting blood draw and to answer questionnaires about 2 weeks after treatment. Three months after the end of treatment, you will be asked to complete a series of questionnaires online.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Insomnia,sleep,chronic sleep disturbance
  • Age: 21 years - 60 years
  • Gender: All


Updated on 19 Feb 2024. Study ID: 827001

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.